Zhen ci yan jiu = Acupuncture research · 2025
[Effects of moxibustion on ferroptosis in Crohn's disease mice through p53-mediated regulation of the SLC7A11/GSH/GPX4 antioxidant axis].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Di-Can, Zhou Jing-Ying, Wang Lu-Yao, Lu Peng-Hui, Liu Mi
Аннотация
OBJECTIVES: To observe the effects of moxibustion at the acupoint "Tianshu" (ST25) on intestinal inflammatory injury in Crohn's disease (CD) mice, and to investigate the mechanism by which the tumor protein p53 modulates the antioxidant axis of the solute carrier family 7 member 11 (SLC7A11)/glutathione (GSH)/glutathione peroxidase 4 (GPX4) and ferroptosis in CD mice.
METHODS: SPF-grade C57BL/6 wild-type mice were randomly divided into normal, model, and moxibustion groups, with 10 mice in each group. In the model and moxibustion groups, the 2% dextran sulfate sodium solution was used to induce CD mice model. The moxibustion group received indirect moxibustion with fine moxa sticks at bilateral ST25 for 30 min per session, once daily, for 14 consecutive days. The body mass, fecal properties, and fecal occult blood were recorded and the disease activity index (DAI) score was determined before and after treatment. At the end of the moxibustion intervention, colonic pathological damage was observed using HE staining. The serum contents of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-17, and the contents of 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), GSH, ferrous iron (Fe2+), and the activity of superoxide dismutase (SOD) of colon tissue were measured by ELISA. The reactive oxygen species (ROS) level in colon tissue was detected by immunofluorescence. The protein expression levels of p53, SLC7A11, and GPX4 in colon tissue were determined by Western blot.
RESULTS: In the model group, the colon tissue exhibited extensive breaks and defects in the intestinal epithelium, disorganized glandular arrangement, and a large number of inflammatory cell infiltration. After the intervention in the moxibustion group, the intestinal epithelial continuity was restored, the intestinal mucosa was mildly swollen, the glands were more neatly arranged, and a small number of inflammatory cells were occasionally scattered of colon tissue. Compared with the normal group, mice in the model group had obvious disease symptoms, with elevated DAI score (P<0.01), increased serum contents of TNF-α, IL-1β, and IL-17 (P<0.01), higher contents of 4-HNE, MDA, and Fe2+ (P<0.01) and reduced GSH contents and SOD activity (P<0.01) in colon tissue, increased expression level of ROS (P<0.01), and the protein expression of p53 was up-regulated (P<0.01), the protein expressions of SLC7A11 and GPX4 were down-regulated (P<0.01). Compared with the model group, mice in the moxibustion group showed alleviated disease symptoms with lower DAI score (P<0.01), decreased serum contents of TNF-α, IL-1β, and IL-17 (P<0.01), reduced contents of 4-HNE, MDA, and Fe2+ (P<0.01, P<0.05) and increased GSH contents and SOD activity (P<0.01) in colon tissue, decreased expression level of ROS (P<0.01), and the protein expression of p53 was down-regulated (P<0.01), the protein expressions of SLC7A11 and GPX4 were up-regulated (P<0.05, P<0.01).
CONCLUSIONS: Moxibustion at ST25 reduced intestinal inflammation in CD mice, probably through down-regulating p53 protein expression, enhancing the SLC7A11/GSH/GPX4 antioxidant axis activity, and reducing lipid peroxidation and ferroptosis in colonic tissues, thus maintaining intestinal iron homeostasis.
METHODS: SPF-grade C57BL/6 wild-type mice were randomly divided into normal, model, and moxibustion groups, with 10 mice in each group. In the model and moxibustion groups, the 2% dextran sulfate sodium solution was used to induce CD mice model. The moxibustion group received indirect moxibustion with fine moxa sticks at bilateral ST25 for 30 min per session, once daily, for 14 consecutive days. The body mass, fecal properties, and fecal occult blood were recorded and the disease activity index (DAI) score was determined before and after treatment. At the end of the moxibustion intervention, colonic pathological damage was observed using HE staining. The serum contents of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-17, and the contents of 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), GSH, ferrous iron (Fe2+), and the activity of superoxide dismutase (SOD) of colon tissue were measured by ELISA. The reactive oxygen species (ROS) level in colon tissue was detected by immunofluorescence. The protein expression levels of p53, SLC7A11, and GPX4 in colon tissue were determined by Western blot.
RESULTS: In the model group, the colon tissue exhibited extensive breaks and defects in the intestinal epithelium, disorganized glandular arrangement, and a large number of inflammatory cell infiltration. After the intervention in the moxibustion group, the intestinal epithelial continuity was restored, the intestinal mucosa was mildly swollen, the glands were more neatly arranged, and a small number of inflammatory cells were occasionally scattered of colon tissue. Compared with the normal group, mice in the model group had obvious disease symptoms, with elevated DAI score (P<0.01), increased serum contents of TNF-α, IL-1β, and IL-17 (P<0.01), higher contents of 4-HNE, MDA, and Fe2+ (P<0.01) and reduced GSH contents and SOD activity (P<0.01) in colon tissue, increased expression level of ROS (P<0.01), and the protein expression of p53 was up-regulated (P<0.01), the protein expressions of SLC7A11 and GPX4 were down-regulated (P<0.01). Compared with the model group, mice in the moxibustion group showed alleviated disease symptoms with lower DAI score (P<0.01), decreased serum contents of TNF-α, IL-1β, and IL-17 (P<0.01), reduced contents of 4-HNE, MDA, and Fe2+ (P<0.01, P<0.05) and increased GSH contents and SOD activity (P<0.01) in colon tissue, decreased expression level of ROS (P<0.01), and the protein expression of p53 was down-regulated (P<0.01), the protein expressions of SLC7A11 and GPX4 were up-regulated (P<0.05, P<0.01).
CONCLUSIONS: Moxibustion at ST25 reduced intestinal inflammation in CD mice, probably through down-regulating p53 protein expression, enhancing the SLC7A11/GSH/GPX4 antioxidant axis activity, and reducing lipid peroxidation and ferroptosis in colonic tissues, thus maintaining intestinal iron homeostasis.